Neuroscientific Biopharmaceuticals Ltd. (AU:NSB) has released an update.
NeuroScientific Biopharmaceuticals Limited reported a significant increase of 130.34% in profit after tax for the fiscal year ended June 30, 2024, despite a decrease in income from ordinary activities by 52.76%. The company also disclosed that no dividends will be distributed for the year, and its net tangible assets per share saw a marginal increase from 3.50 cents to 3.52 cents. An unqualified audit opinion was issued for the financial statements, ensuring their accuracy and compliance.
For further insights into AU:NSB stock, check out TipRanks’ Stock Analysis page.
